| Gene Set | Leading Edge Genes |
|---|
| DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | PRDX6, MAGOH, POLE3, COPS5, HMGCR, PPP2CB, ALG5, CCT3, YKT6, PTPLA, SLBP, ITPA, PSMA3, TXNL1, ICT1, UBE2V2, ATP5O, PSMB5, TRAPPC3, ACTR1A, GTF2B, ALKBH1, PDHA1, CRIP1, DHCR24, IDE, COPS3, SUCLA2, BNIP3, LSM8, PDCD6, NDUFV2, UBAP2, PAPSS1, TCEB1, CCT6A, MED6, AMD1, NHP2L1, NDUFS4, PSMD3, KHDRBS1, HADHA, SFRS1, HEBP2, RANBP1, NDUFB6, DCTN6, XRCC5, PRDX3, CFDP1, POLR2C, EIF5, SQLE, SNX3, NMD3, DBF4, POLR2K, NDUFB5, MIF, UCHL5, PCTP, EMP3, UQCRC1, ACP1, TCP1, SSBP1, ST13, RNF14, NDUFAB1, BCKDHB, AK2, RAB4A, DPP3, DRG2, GTPBP4, LSM5, PSMC6, SNX5, DRAP1, HPRT1, COPS2, LASS2, TOMM22, PSMC3, MTCH2, RER1, RAB11A, PABPN1, UBE2N, SNRPB2, PSMB2, PSMD2, CPOX, PSMD12, SUCLG1, DRG1, PSMD8, CALM1, GTF2H1, SRP19, MRPS31, QDPR |
| KEGG PARKINSONS DISEASE | NDUFA6, UQCRC1, ATP5O, NDUFB7, NDUFS6, SDHB, NDUFS4, NDUFB8, UQCRH, UQCRQ, NDUFB6, NDUFAB1, COX7C, NDUFS3, NDUFA2, NDUFC1 |
| KEGG HUNTINGTONS DISEASE | NDUFB8, POLR2K, NDUFA2, POLR2G, NDUFB7, ATP5O, UQCRC1, NDUFA6, NDUFS4, CLTB, NDUFB6, POLR2H, NDUFAB1, DCTN2, NDUFS3, POLR2C, NDUFC1 |
| REACTOME CELL CYCLE MITOTIC | PSMC5, PCNA, RRM2, PPP2CB, RFC2, ZWINT, PLK1, DBF4, CCNB1, PSMB6, PSMC3, PPP2CA, CCDC99, ITGB3BP, PSMB7, RPA3, PSMA3, CCNA2, MNAT1, PSMB2, PSMD2, KIF18A, PSMB5, PSMD6, PSMD12, PSMD8, DCTN2, PSMC6, BIRC5 |
| PAL PRMT5 TARGETS UP | NDUFA13, CD99, TMPO, NDUFB8, PSMC3, SLBP, LOXL1, TMEM93, EMP3, PSMB5, APEX1, EIF1AY, GSTZ1, LSM3, PSMD6, ST7, CKS2, COPS3, CFDP1, MRPL48 |
| REACTOME MITOTIC M M G1 PHASES | PSMC5, PPP2CB, MLF1IP, ZWINT, PLK1, PSMB6, PSMC3, PPP2CA, CCDC99, ITGB3BP, PSMB7, PSMA3, PSMB2, PSMD2, PSMB5, KIF18A, PSMD6, PSMD12, PSMD8, PSMC6, BIRC5 |
| TARTE PLASMA CELL VS PLASMABLAST DN | PSMC5, NDUFV2, PCNA, UCHL3, RRM2, SDHB, TMPO, TCEB1, CCNB1, PAK2, HSPE1, PSMA3, PHB, CCNA2, ICT1, SNRPB2, TYMS, NDUFB7, ATP5O, PSMB2, CPOX, NASP, CCT5, TCP1, DHCR24, CKS2, IDH2, EIF5 |
| KINSEY TARGETS OF EWSR1 FLII FUSION UP | SQLE, PCNA, MAGOH, SNX3, RRM2, POLE3, TMPO, PLK1, ATG5, DBF4, CCNB1, PAK2, CCDC99, SLBP, POLR2K, UCHL5, TMEM93, CDCA3, ACP1, CYB5B, TCP1, MAP3K7, TIPIN, COPS3, AK2, RNASEH2A, SUCLA2, TPRKB, RFC2, TCEB1, TOMM22, MED6, PSMC3, ITGB3BP, GGA2, ASRGL1, COX4NB, THAP1, MRPL15, TMEM70, HMMR, CYB5A, E2F6, KIF18A, GTF2A1, SFRS2, GORASP2, GTF2A2, RANBP1, CALM1, GPD2, PRDX3, UBE3A, MRPL48, BIRC5 |
| GARY CD5 TARGETS DN | PSMC5, RRM2, PAK1IP1, CCNB1, RAN, HSPA14, SAP18, NDUFB7, PSMB5, LANCL2, PQBP1, CYB5B, ASNSD1, MAP3K7, TIPIN, MGAT2, BXDC5, PMPCA, GTPBP4, PSMC6, RFC2, LCMT2, PSMC3, MRPL35, MRPS11, PFDN1, MRPL15, UFM1, OIP5, PDCD5, DNAJA1, SFRS2, DRG1, GTF2H1, HINT1, EIF5, BIRC5 |
| WEI MYCN TARGETS WITH E BOX | TIMM10, ARPC5L, PKNOX1, UCHL3, RRM2, POLE3, RPP30, CCDC99, CSRP2, PSMA3, ICT1, HSPA14, PMM2, TIPIN, COPS3, ZBTB38, TUBB6, PDCD6, MRPL22, TPRKB, GOLT1B, TCEB1, MRPL35, AMD1, GGA2, MTCH2, MRPL15, HMMR, TMEM70, PABPN1, PTS, MRPL18, VRK1, PSMD2, PSMD12, SUCLG1, CALM1, POP7, GPD2, POLR3K, SRP19, IDI1, EIF5, MRPL39, BIRC5 |
| REACTOME HIV INFECTION | PSMC5, TCEB2, TCEB1, PSMB6, PSMC3, PAK2, RAN, POLR2K, PSMB7, PSMA3, POLR2G, MNAT1, PSMB2, RBX1, ERCC3, PSMD2, PSMB5, PSMD6, SLC25A4, RAE1, GTF2B, GTF2A1, PSMD12, PSMD8, RANBP1, POLR2H, NUP93, GTF2H1, BANF1, POLR2C, PSMC6 |
| SHEDDEN LUNG CANCER POOR SURVIVAL A6 | PCNA, MMP12, RRM2, ZWINT, DBF4, ATG5, CCNB1, RAN, YKT6, PBK, SLBP, MIF, CDCA3, RECQL4, ACP1, TCP1, CKS2, MRPL13, RASAL2, RFC2, TPRKB, MTCH2, HMMR, CCNA2, PSMB2, DNAJA1, KIF18A, PSMD12, HEXIM1, CCT5, GPD2, BIRC5 |
| BLUM RESPONSE TO SALIRASIB DN | PCNA, RRM2, RFC2, TMPO, PLK1, PRSS23, ITGB3BP, PBK, HMMR, CCNA2, NDUFA2, HSPA14, CYB5A, RBX1, GAMT, VRK1, RECQL4, RANBP1, DHCR24, CKS2, PRDX3, CHST12, RNASEH2A, RAB4A, CRIP2, LSM5 |
| ZHANG BREAST CANCER PROGENITORS UP | RRM2, NVL, TMPO, DBF4, TULP3, MRPS33, MED6, PBK, RPA3, CCNA2, RNF7, DNAJA1, NDUFS4, SSBP1, SUCLA2, LSM5, PUS7L, NDUFC1 |
| CORUM PA700-20S-PA28 COMPLEX | PSMB2, PSMC5, PSMD2, PSMB5, PSMD6, PSMD3, PSMD12, PSMB6, PSMD8, PSMC3, PSMB7, PSMB3, PSMA3, PSMC6 |
| BASAKI YBX1 TARGETS UP | ARPC5L, EPHA2, TPRKB, RFC2, PLK1, PRSS23, CCNB1, PSMB6, CCDC99, PBK, CCNA2, CDCA3, PSMD2, TNFRSF12A, NUP93, HINT1, BIRC5, SNX5 |
| MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | NDUFA13, TTRAP, NASP, CCT5, MRPS12, PSMD8, SSBP1, RAN, LSM5, TYMS |
| BIOCARTA PROTEASOME PATHWAY | PSMB2, PSMB5, PSMB7, PSMA3, PSMB3, PSMB6 |
| LINDGREN BLADDER CANCER CLUSTER 3 UP | PCNA, RRM2, TMPO, PLK1, PAK1IP1, PEPD, DBF4, ATG5, MRPS12, CCNB1, RPA3, TYMS, VRK1, INSIG1, NASP, SUCLG1, CKS2, RNASEH2A, AK2, IDH2, MRPL48, TFG, BIRC5 |
| DANG MYC TARGETS UP | APEX1, SLC25A3, PCNA, RFC2, H2AFZ, CCNB1, CCT5, CKS2, HSPE1, PHB, UXT, TYMS |
| REACTOME G1 S TRANSITION | PSMC5, PSMD2, PSMB5, PCNA, RRM2, PSMD6, PSMB6, CCNB1, DBF4, PSMD8, PSMC3, PSMB7, RPA3, CCNA2, PSMC6 |
| CORUM 26S PROTEASOME | PSMB2, PSMC5, PSMB5, PSMB6, PSMC3, PSMB7, PSMA3, PSMB3, PSMC6 |
| BORCZUK MALIGNANT MESOTHELIOMA UP | PDCD6, PCNA, SLC25A3, SCCPDH, COPS5, H2AFZ, TCEB1, CCNB1, PSMB6, PAK2, CCT3, RAN, YKT6, PSMB7, BRP44, PSMD2, DNAJA1, SFRS1, RAB32, CCT5, SSBP1, PSMD8, CKS2, XRCC5, SEC61G, RAB4A |
| MUELLER PLURINET | PCNA, TTRAP, RFC2, TMPO, CCNB1, ITGB3BP, HSPE1, RPA3, PSMA3, HMMR, CCNA2, HSPA14, MNAT1, APEX1, RECQL4, LSM3, SFRS2, DHCR24, POP7, CKS2, COPS3, U2AF1, LSM5, BIRC5 |
| CROONQUIST IL6 DEPRIVATION DN | PCNA, NASP, PLK1, CCNB1, CKS2, HMMR, OIP5, CCNA2, AASS |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | PDCD6, TTRAP, PAK1IP1, NASP, ANKRD49, MRPS12, DBF4, CCT5, PSMD8, SSBP1, RAN, COMMD4, SHFM1, LSM5, TYMS |
| GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP | |
| NCI PAUSING AND RECOVERY OF ELONGATION | |
| PUJANA BRCA1 PCC NETWORK | |
| LI WILMS TUMOR VS FETAL KIDNEY 1 DN | |
| REACTOME RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE | |
| NCI RNA POLYMERASE II TRANSCRIPTION PRE INITIATION | |
| REACTOME NUCLEOTIDE EXCISION REPAIR | |
| SANA RESPONSE TO IFNG DN | |
| CORUM DDB2 COMPLEX | |
| NCI HOST INTERACTIONS OF HIV FACTORS | |
| NCI VIRAL MESSENGER RNA SYNTHESIS | HNRPM, POLR2F, CD2BP2, SFRS2, POLR2H, POLR2K, U2AF1, POLR2C, PCBP1, RBMX, POLR2J, POLR2G, HNRPF |
| NUYTTEN EZH2 TARGETS DN | |
| NCI ORC1 REMOVAL FROM CHROMATIN | |
| ZHAN VARIABLE EARLY DIFFERENTIATION GENES DN | |
| KEGG SPLICEOSOME | MAGOH, RBM22, BUD31, PRPF4, PCBP1, SNRPB2, LSM3, PQBP1, SFRS2, SFRS1, LSM6, U2AF1, RBM8A, SNRPD2, RBMX, LSM5 |
| NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | |
| REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | |
| NCI FORMATION OF THE EARLY ELONGATION COMPLEX | |
| REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | |
| NCI RNA POLYMERASE II TRANSCRIPTION ELONGATION | ERCC3, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| CORUM PA700 COMPLEX | |
| LE EGR2 TARGETS UP | |
| CORUM PA28GAMMA-20S PROTEASOME | |
| REACTOME HOST INTERACTIONS OF HIV FACTORS | |
| REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | |
| REACTOME SYNTHESIS OF DNA | |
| REACTOME TAT MEDIATED HIV1 ELONGATION ARREST AND RECOVERY | |
| NCI APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | |
| REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | MAGOH, POLR2L, SLBP, POLR2B, POLR2K, PRPF4, PCBP1, PABPN1, POLR2J, POLR2G, NUDT21, SNRPB2, POLR2F, CD2BP2, RAE1, SFRS2, SFRS1, NUP37, POLR2H, NUP93, RBM8A, SNRPD2, U2AF1, POLR2C, RBMX |
| NCI VPU MEDIATED DEGRADATION OF CD4 | |
| NCI AUTODEGRADATION OF CDH1 BY CDH1 APC C | |
| REACTOME LATE PHASE OF HIV LIFE CYCLE | ERCC3, GTF2A1, GTF2B, RAE1, TCEB1, TCEB2, RANBP1, NUP93, RAN, POLR2H, GTF2H1, POLR2K, POLR2C, MNAT1, POLR2G |
| NCI ELONGATION ARREST AND RECOVERY | |
| NCI CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | |
| MORI IMMATURE B LYMPHOCYTE DN | |
| REACTOME TELOMERE MAINTENANCE | |
| CORUM LSM1-7 COMPLEX | |
| CAFFAREL RESPONSE TO THC 24HR 5 UP | |
| REACTOME MITOTIC PROMETAPHASE | |
| REACTOME HIV1 TRANSCRIPTION INITIATION | |
| NCI CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | |
| NCI RNA POLYMERASE II TRANSCRIPTION INITIATION | |
| NCI RNA POLYMERASE II HIV 1 PROMOTER ESCAPE | |
| NCI PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | |
| REACTOME REGULATION OF ORNITHINE DECARBOXYLASE | |
| NCI MRNA SPLICING MAJOR PATHWAY | MAGOH, POLR2L, POLR2K, PRPF4, PABPN1, POLR2J, POLR2G, NUDT21, SNRPB2, HNRPM, POLR2F, CD2BP2, SFRS2, SFRS1, POLR2H, RBM8A, U2AF1, POLR2C, HNRPF |
| FOURNIER ACINAR DEVELOPMENT LATE 2 | |
| MOHANKUMAR TLX1 TARGETS UP | |
| MORI LARGE PRE BII LYMPHOCYTE UP | |
| REACTOME HIV1 TRANSCRIPTION ELONGATION | ERCC3, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| CORUM SPLICEOSOME | |
| NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | |
| NCI PAUSING AND RECOVERY OF HIV 1 ELONGATION | |
| NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1 | |
| NCI TAT MEDIATED HIV 1 ELONGATION ARREST AND RECOVERY | |
| NCI VIF MEDIATED DEGRADATION OF APOBEC3G | |
| VECCHI GASTRIC CANCER EARLY UP | |
| NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | |
| CORUM LSM2-8 COMPLEX | |
| REACTOME FORMATION AND MATURATION OF MRNA TRANSCRIPT | ERCC3, MAGOH, CD2BP2, GTF2A1, GTF2B, TCEB2, SFRS2, TCEB1, GTF2A2, POLR2H, GTF2H1, POLR2K, U2AF1, POLR2C, POLR2G, MNAT1 |
| MISSIAGLIA REGULATED BY METHYLATION DN | |
| NCI MRNA SPLICING MINOR PATHWAY | POLR2F, SFRS2, SFRS1, POLR2L, POLR2H, POLR2K, POLR2C, POLR2J, POLR2G |
| DODD NASOPHARYNGEAL CARCINOMA DN | |
| BENPORATH PROLIFERATION | PCNA, RRM2, DBF4, RANBP1, CKS2, COX4NB, PSMA3, IDH2, GTPBP4, SHFM1, PDCD5, PTS, BIRC5 |
| REACTOME TRANSCRIPTION OF THE HIV GENOME | ERCC3, GTF2A1, GTF2B, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| NCI HIV 1 TRANSCRIPTION INITIATION | |
| NCI TAT MEDIATED ELONGATION OF THE HIV 1 TRANSCRIPT | ERCC3, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| NCI RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE | |
| NCI RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE1 | |
| WHITEFORD PEDIATRIC CANCER MARKERS | CKS2, PCNA, RNASEH2A, RECQL4, RRM2, TMPO, CCNA2, CCNB1, BIRC5 |
| RHODES UNDIFFERENTIATED CANCER | |
| REACTOME CELL CYCLE CHECKPOINTS | |
| ALONSO METASTASIS UP | |
| NCI REMOVAL OF LICENSING FACTORS FROM ORIGINS | |
| REACTOME RNA POLYMERASE II TRANSCRIPTION | ERCC3, MAGOH, POLR2F, GTF2B, SFRS2, TCEB1, TCEB2, GTF2A2, GTF2H1, POLR2K, RBM8A, U2AF1, POLR2C, POLR2J, MNAT1 |
| ODONNELL TARGETS OF MYC AND TFRC DN | |
| ZHAN MULTIPLE MYELOMA PR UP | |
| REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | |
| REACTOME MRNA SPLICING | MAGOH, POLR2L, POLR2K, PRPF4, PABPN1, POLR2J, POLR2G, NUDT21, SNRPB2, CD2BP2, POLR2F, SFRS2, SFRS1, POLR2H, U2AF1, RBM8A, POLR2C |
| REACTOME RNA POLYMERASE I III AND MITOCHONDRIAL TRANSCRIPTION | |
| NCI HIV 1 ELONGATION ARREST AND RECOVERY | |
| REACTOME GLOBAL GENOMIC NER | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF SECURIN | |
| NCI FORMATION OF THE HIV 1 EARLY ELONGATION COMPLEX | |
| MARKEY RB1 ACUTE LOF DN | |
| REACTOME ELONGATION AND PROCESSING OF CAPPED TRANSCRIPTS | ERCC3, MAGOH, CD2BP2, TCEB2, SFRS1, POLR2L, TCEB1, POLR2H, GTF2H1, POLR2K, POLR2C, PABPN1, POLR2G, MNAT1, SNRPB2 |
| REACTOME TRANSCRIPTION COUPLED NER | |
| NCI MRNA CAPPING | |
| NCI PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | |
| NCI RNA POLYMERASE II TRANSCRIPTION | |
| NCI MITOTIC PROMETAPHASE | |
| CROONQUIST NRAS SIGNALING DN | |
| REACTOME VIRAL MESSENGER RNA SYNTHESIS | |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | |
| REACTOME METABOLISM OF RNA | |
| NCI HIV 1 TRANSCRIPTION ELONGATION | |
| REACTOME DNA REPLICATION PRE INITIATION | |
| REACTOME FORMATION OF THE EARLY ELONGATION COMPLEX | |
| NCI PAUSING AND RECOVERY OF TAT MEDIATED HIV 1 ELONGATION | |
| NCI FORMATION OF HIV 1 ELONGATION COMPLEX CONTAINING HIV 1 TAT | ERCC3, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| REACTOME REGULATION OF APC ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | |
| FURUKAWA DUSP6 TARGETS PCI35 DN | |
| REACTOME CDC20 PHOSPHO APC MEDIATED DEGRADATION OF CYCLIN A | |
| REACTOME RNA POLYMERASE I PROMOTER CLEARANCE | |
| REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | |
| DING LUNG CANCER EXPRESSION BY COPY NUMBER | |
| NCI FORMATION OF RNA POL II ELONGATION COMPLEX | ERCC3, TCEB1, TCEB2, POLR2H, GTF2H1, POLR2K, POLR2C, POLR2G, MNAT1 |
| WINNEPENNINCKX MELANOMA METASTASIS UP | DNAJA1, PCNA, RRM2, CCNB1, CCT5, RANBP1, CKS2, ENY2, RPA3, BIRC5 |
| NCI ELONGATION OF INTRON CONTAINING TRANSCRIPTS AND CO TRANSCRIPTIONAL MRNA SPLICING | |
| LEE LIVER CANCER SURVIVAL DN | |
| NCI RNA POLYMERASE II PROMOTER ESCAPE | |
| LUI THYROID CANCER CLUSTER 3 | |
| NCI ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | |
| NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1 | |
| NCI CDC20 PHOSPHO APC C MEDIATED DEGRADATION OF CYCLIN A | |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | |
| CORUM 20S PROTEASOME | |
| REACTOME MRNA SPLICING MINOR PATHWAY | POLR2H, POLR2K, POLR2C, POLR2G |
| NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC | |
| WEST ADRENOCORTICAL TUMOR UP | |
| YU MYC TARGETS UP | |
| REACTOME ORC1 REMOVAL FROM CHROMATIN | |
| REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC | |
| CORUM RNA POLYMERASE II HOLOENZYME COMPLEX | |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER UP | |
| REACTOME S PHASE | |
| BOYAULT LIVER CANCER SUBCLASS G3 UP | LRRC59, COPS5, TPRKB, GOLT1B, CYB5B, PAK1IP1, TCEB1, CCT5, TIPIN, ZWILCH, POLR2K, SEC61G, HMMR, CCNA2, PSMC6, UBE2V2 |
| NCI FORMATION AND MATURATION OF MRNA TRANSCRIPT | |
| RHODES CANCER META SIGNATURE | |
| NCI RNA POLYMERASE II TRANSCRIPTION INITIATION AND PROMOTER CLEARANCE | |
| REACTOME TRANSCRIPTION | ERCC3, MAGOH, POLR2F, TCEB2, SFRS2, TCEB1, GTF2A2, GTF2H1, POLR2K, RBM8A, U2AF1, POLR2C, POLR2J, MNAT1 |
| NCI HIV 1 TRANSCRIPTION PRE INITIATION | |
| REACTOME M G1 TRANSITION | |
| NCI SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | |
| REACTOME HIV LIFE CYCLE | ERCC3, GTF2A1, GTF2B, RAE1, TCEB1, TCEB2, RANBP1, NUP93, RAN, POLR2H, GTF2H1, POLR2K, BANF1, POLR2C, MNAT1, POLR2G |
| NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION | |
| NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A | |
| NCI TRANSCRIPTION OF THE HIV GENOME | |
| REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | |